Insider · CIK 0001814943
Michael J. McBreen
Files at IART (INTEGRA LIFESCIENCES HOLDINGS CORP). First filing Dec 3, 2024, latest Dec 3, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IART: INTEGRA LIFESCIENCES HOLDINGS CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | INTEGRA LIFESCIENCES HOLDINGS CORP | $41k 1,700 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | IART INTEGRA LIFESCIENCES HOLDINGS CORP | FTax withholding Common Stock | -446 | $23.95 | $11k | 53,451 | Mar 13, 2025 |
| Mar 11, 2025 | IART INTEGRA LIFESCIENCES HOLDINGS CORP | FTax withholding Common Stock | -1,587 | $23.95 | $38k | 51,864 | Mar 13, 2025 |
| Mar 11, 2025 | IART INTEGRA LIFESCIENCES HOLDINGS CORP | AGrant or award Common Stock | +18,480 | $0.00 | $0 | 70,344 | Mar 13, 2025 |
| Mar 11, 2025 | IART INTEGRA LIFESCIENCES HOLDINGS CORP | AGrant or award Non- Qualified Stock Option (right to buy)derivative | +39,132 | $0.00 | $0 | 39,132 | Mar 13, 2025 |
| Mar 10, 2025 | IART INTEGRA LIFESCIENCES HOLDINGS CORP | FTax withholding Common Stock | -1,229 | $22.61 | $28k | 54,953 | Mar 11, 2025 |
| Mar 10, 2025 | IART INTEGRA LIFESCIENCES HOLDINGS CORP | FTax withholding Common Stock | -1,056 | $22.61 | $24k | 53,897 | Mar 11, 2025 |
| Dec 2, 2024 | IART INTEGRA LIFESCIENCES HOLDINGS CORP | SOpen-market sale Common Stock | -1,700 | $24.16 | $41k | 56,182 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.